Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDABVC BioPharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
ABVC BioPharma, Inc. Earnings Date And Information
ABVC BioPharma, Inc. last posted its earnings results on Monday, May 15th, 2023. The company reported $-0.6 earnings per share for the quarter, missing analysts' consensus estimates of $-0.5 by $0.1. The company had revenue of 389,276 for the quarter and had revenue of 152,430 for the year. ABVC BioPharma, Inc. has generated $-2 earnings per share over the last year ($-2.43 diluted earnings per share) and currently has a price-to-earnings ratio of -0.95. ABVC BioPharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based on prior year's report dates.
ABVC BioPharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | N/A | -$0.02 | N/A | $389,276 | $389,276 |
| 08/14/2024 | Q2 2024 | N/A | -$0.09 | N/A | $117,142 | $117,142 |
| 05/17/2024 | Q1 2024 | N/A | -$0.40 | N/A | N/A | $1,205 |
| 03/14/2024 | Q4 2023 | N/A | -$0.39 | N/A | N/A | $2,165 |
| 11/15/2023 | Q3 2023 | N/A | -$0.82 | N/A | $300,000 | $15,884 |
| 08/14/2023 | Q2 2023 | N/A | -$0.68 | N/A | $300,000 | $6,109 |
| 05/15/2023 | Q1 2023 | -$0.50 | -$0.02 | 0.48 | N/A | $128,272 |
| 03/31/2023 | Q4 2022 | -$1.90 | -$1.38 | 0.52 | N/A | $588,994 |
| 11/14/2022 | Q3 2022 | -$2.00 | -$1.16 | 0.84 | $26,176 | $42,269 |
| 08/15/2022 | Q2 2022 | -$2.00 | -$0.62 | 1.38 | $25,917 | $312,860 |
| 05/16/2022 | Q1 2022 | N/A | -$2.00 | N/A | N/A | $25,660 |
| 03/31/2022 | Q4 2021 | -$0.04 | -$3.10 | -3.06 | N/A | $-37,793 |
| 11/15/2021 | Q3 2021 | -$0.40 | -$0.70 | -0.3 | $113,257 | $98,999 |
| 08/11/2021 | Q2 2021 | -$0.04 | -$0.80 | -0.76 | $263,000 | $31,440 |
| 05/10/2021 | Q1 2021 | N/A | -$0.50 | N/A | N/A | $263,150 |
| 03/16/2021 | Q4 2020 | -$0.10 | -$2.50 | -2.4 | N/A | $62,193 |
| 11/17/2020 | Q3 2020 | N/A | -$0.90 | N/A | N/A | $115,553 |
| 08/14/2020 | Q2 2020 | N/A | -$0.90 | N/A | N/A | $226,513 |
| 06/29/2020 | Q1 2020 | N/A | -$0.60 | N/A | N/A | $78,786 |
| 05/15/2020 | Q4 2019 | N/A | -$0.60 | N/A | N/A | $99,962 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ABVC BioPharma, Inc. Earnings: FAQ's
ABVC BioPharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based offlast year's report dates.
The conference call for ABVC BioPharma, Inc.'s latest earnings report can be listened to online.
The conference call transcript for ABVC BioPharma, Inc.'s latest earnings report can be read online.
ABVC BioPharma, Inc. (:ABVC) has a recorded annual revenue of $152,430.
ABVC BioPharma, Inc. (:ABVC) has a recorded net income of $-10,515,656.ABVC BioPharma, Inc. has generated $-2.43 earnings per share over the last four quarters.
ABVC BioPharma, Inc. (:ABVC) has a price-to-earnings ratio of -0.95 and price/earnings-to-growth ratio is -0.02.